SIEGFRIED

"Company With SIEGFRIED as a preferred partner, customers can expect a noticeable additional benefit. We combine a long tradition of pharmaceuticals and chemistry with the innovative approach of an ""integrated supplier"". As a result, they benefit from synergies, specialist knowledge and added value. We offer you tailor-made solutions for services in the development and production of active substances, intermediates, complex dosage forms and products from our own portfolio. As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in our customers' value chain. Our pharmaceutical industry partners benefit from a wide range of services – from the development of active ingredients to development services for ready-to-use drugs, their approval and production to packaging and logistics. As a former fully integrated pharmaceutical company, SIEGFRIED is now one of the few suppliers that can carry out both the development of active ingredients and finished drugs under one roof. This combination of experience and know-how is unique in the CDMO market. SIEGFRIED has expanded its technological and geographic presence around the globe in recent years. In addition to technological competence and global presence, the focus is on controlling the overall processes for all products in order to ensure the greatest possible security. SIEGFRIED adheres to the strictest quality, production and marketing requirements. Our reputation in this field is underscored by our unparalleled success in inspections - performed by both authorities and customers. Our development and production sites are in Switzerland, the USA, Malta, China, Germany, France and Spain. The company currently employs around 3,500 people and generated sales of CHF 845.1 million in the 2020 financial year. SIEGFRIED Holding AG is listed on the Zurich Stock Exchange (SIX: SFZN)."